Brief: Bayer AG Says Co To Consolidate U.S. Glyphosate Business Into Distinct Entity Operating As Ruveon
01/07/2026 23:29
BRIEF-Bayer AG Says Co To Consolidate U.S. Glyphosate Business Into Distinct Entity Operating As Ruveon July 1 (Reuters) - Bayer AG BAYGn.DE:
BAYER AG - BAYER GROUP TO CONSOLIDATE U.S. GLYPHOSATE BUSINESS INTO DISTINCT ENTITY OPERATING AS RUVEON
Further company coverage: [BAYGn.DE]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bayer AG
See all newsBrief: Bayer Says Finerenone Slowed Kidney Decline In CKD
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant
Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9
Brief: Bayer To Present New Finerenone Data Across Chronic Kidney Disease With And Without Diabetes At Asn Kidney Week 2026
Brief: FDA Approves Once-Weekly Generic Hormone Therapy Patch For Women